论文部分内容阅读
医药专利制度建立的目的是为了鼓励创造和发明,同时维护制药商的垄断利益,这与发展中国家的人民享有的健康权相冲突,为解决这一冲突,Trips协议中对专利的强制许可制度和专利药物的平行进口进行了规定。从Trips协议关于药物专利保护规范的变迁过程中,本文建议为维护制药商的合理利益,同时维护发展中国家人民的健康权,应该在健全发展中国家专利保护制度的同时,建立专利制度外的药物研发激励机制,同时实施差别定价机制。
The purpose of the medical patent system was to encourage the creation and invention of pharmaceuticals while at the same time safeguarding the monopoly interests of pharmaceutical manufacturers, which conflicts with the right to health enjoyed by the people of developing countries. In order to resolve this conflict, the Compulsory Licensing System of the Trips And parallel imports of patented drugs are regulated. From the Trips agreement on the changes in the norms of the protection of pharmaceutical patents, this article suggests that in order to safeguard the reasonable interests of pharmaceutical manufacturers while safeguarding the rights of people in developing countries, we should, while perfecting the system of patent protection in developing countries, establish patent protection systems Incentives for drug development, while implementing differential pricing mechanisms.